The April 2024 month in review features HCPLive’s top coverage of resmetirom, other key hepatic pipeline updates, and recent research about hepatitis C virus.
The modified difference-in-differences analysis found notable increases in DAA use after state Medicaid programs relaxed certain coverage restrictions.
Using a Bayesian modelling approach, Ramanan Laxminarayan and colleagues, explore the global impact of a maternal vaccine against Klebsiella pneumoniae on neonatal sepsis and associated mortality.